Publications by authors named "V Naumenko"

Oncolytic viruses (OV) are designed to selectively infect and kill cancer cells, while simultaneously eliciting antitumour immunity. The mechanism is expected to originate from infected cancer cells. However, recent reports of tumour regression unaccompanied by cancer cell infection suggest a more complex mechanism of action.

View Article and Find Full Text PDF

Conventional dendritic cells (cDCs) generate protective cytotoxic T lymphocyte (CTL) responses against extracellular pathogens and tumors. This is achieved through a process known as cross-presentation (XP), and, despite its biological importance, the mechanism(s) driving XP remains unclear. Here, we show that a cDC-specific pore-forming protein called apolipoprotein L 7C (APOL7C) is up-regulated in response to innate immune stimuli and is recruited to phagosomes.

View Article and Find Full Text PDF
Article Synopsis
  • Neutrophils show potential for delivering nanodrugs to tumors, with this study focusing on how they internalize different types of nanoparticles, like liposomes and PLGA.
  • Various techniques were used, including microscopy and flow cytometry, to assess how well neutrophils take up these nanoparticles and how cultivation conditions affect this process.
  • Results indicated that while all nanoparticles were taken up, the mechanisms varied; notably, the presence of plasma and specific immunoglobulins were crucial for the internalization of PLGA nanoparticles, highlighting the role of the external environment in enhancing drug delivery efficacy.
View Article and Find Full Text PDF

Cerebral dopamine neurotrophic factor (CDNF) is an unconventional neurotrophic factor because it does not bind to a known specific receptor on the plasma membrane and functions primarily as an unfolded protein response (UPR) regulator in the endoplasmic reticulum. Data on the effects of CDNF on nonmotor behavior and monoamine metabolism are limited. Here, we performed the intracerebroventricular injection of a recombinant CDNF protein at doses of 3, 10, and 30 μg in C57BL/6 mice.

View Article and Find Full Text PDF

A large body of evidence implies the involvement of brain-derived neurotrophic factor (BDNF) in the pathogenesis of autism spectrum disorders (ASDs). A deficiency of BDNF in the hippocampus and frontal cortex of BTBR mice (a model of autism) has been noted in a number of studies. Earlier, we showed that induction of BDNF overexpression in the hippocampus of BTBR mice reduced anxiety and severity of stereotyped behavior, but did not affect social interest.

View Article and Find Full Text PDF